Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Clinical trial by Moffitt to reduce risk of prostate cancer in black men

Clinical trial by Moffitt to reduce risk of prostate cancer in black men

Comprehensive changes in lifestyle could reverse ageing

Comprehensive changes in lifestyle could reverse ageing

Inside Jersey magazine names Rutgers Cancer Institute of New Jersey physicians among Top Doctors

Inside Jersey magazine names Rutgers Cancer Institute of New Jersey physicians among Top Doctors

Study shows that changes in diet, lifestyle choices may result in longer telomeres

Study shows that changes in diet, lifestyle choices may result in longer telomeres

Gene panel predicts low-risk prostate cancer fate

Gene panel predicts low-risk prostate cancer fate

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

Three-gene biomarker can help determine treatment option for early prostate cancer

Three-gene biomarker can help determine treatment option for early prostate cancer

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

Wistar Institute receives $1.5M grant to prepare potential new prostate cancer drug for clinical use

Global Industry Analysis Report on Companion Diagnostics Market

Global Industry Analysis Report on Companion Diagnostics Market

New study to reduce unwanted side-effects of radiotherapy

New study to reduce unwanted side-effects of radiotherapy

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

IOM’s ‘Delivering High-Quality Cancer Care’ report praised by ASTRO

ASTRO selects Jean B. Owen as 2013 Honorary Member

ASTRO selects Jean B. Owen as 2013 Honorary Member

Metamark reports positive results from clinical validation study of prostate cancer prognostic test

Metamark reports positive results from clinical validation study of prostate cancer prognostic test

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Pathologist experience critical for accurate Gleason score

Pathologist experience critical for accurate Gleason score

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.